Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-84
SponsorBaylor Research Institute

About this trial

The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval.

Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

patients aged 45-84 years of age

Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines

If a patient opts for BBST, they are able and willing to provide blood samples per protocol

Ability to understand and the willingness to participate in the study

Disqualifiers

Patients with a personal history of CRC

Patients with a known high-risk family history of CRC precluding the patient from being average risk

Patients with known diagnosis of inflammatory bowel disease or history of polyps

Patients who are currently symptomatic for CRC such as: blood in the stool

Trial design

Design model

Parallel

Treatments tested in this trial

  • Educational Information via Smartphone App

    Other intervention

    The educational messages will include information about the meaning of a positive test result, the patient's chances of having a CRC detected on colonoscopy, and the importance of early CRC detection.

Treatment groups

5,500 Participants
are divided into 2 treatment groups
Group A: App InterventionExperimental treatment 1 intervention
Group B: Standard SupportNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Blood-Based Screening Test (BBST) Follow-Up

Assess the number of patients with a negative BBST result who accept and complete a follow-up BBST.

Time frame
1 year after initial result

Secondary outcomes

1

Patient Screening Test Preference

Assess patient preference rates and test completion rates for stool tests, colonoscopy, and blood-based CRC screening modalities.

Time frame
1 year
2

Screening Rates

Compare the overall screening rates in the study population to a historical cohort in which blood-based testing was not offered as an option.

Time frame
1 year
3

Intervention Efficacy

Assess whether use of a digital patient navigation tool +/- traditional patient navigation leads to an increased rate of completion of colonoscopy in those with a positive blood or stool test.

Time frame
1 year

Other outcomes

1

Baseline BBST Results

Number of positive and negative BBST results at baseline testing.

Time frame
1 year
2

Follow-Up BBST Results

Number of positive and negative BBST results at follow-up test

Time frame
1 year after initial result
3

BBST+ Follow-Up

Number of BBST positives who received follow-up colonoscopy

Time frame
1 year
4

BBST+/Colonoscopy- Follow-Up

Percentage of BBST-positive/colonoscopy-negative patients who accept and complete the follow-up BBST after negative colonoscopy.

Time frame
1 year after negative colonoscopy

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: